Inflammatory signals associated with hemodialysis
- PMID: 12234313
- DOI: 10.1111/j.1523-1755.2002.kid556.x
Inflammatory signals associated with hemodialysis
Abstract
Background: Inflammation is highly prevalent in chronic hemodialysis patients. Because hemodialysis involves the contact of blood with "foreign" surfaces, and the documented activation of several humoral and cellular pathways during the procedure, the hemodialysis procedure has been suggested as a potential source of inflammation in this patient population. Earlier studies did not provide clear-cut evidence of the potential contribution of the hemodialysis procedure to inflammation, as assessed by markers of inflammation such as cytokine levels and acute-phase protein production.
Methods: Nine patients were studied using primed-constant infusion of l-(l-13C) leucine 2 hours before, during, and 2 hours after a single hemodialysis session. We evaluated the effects of hemodialysis on induction of interleukin-6 (IL-6) production as well as the fractional synthetic rates (FSR) of albumin and fibrinogen, two well-known acute-phase proteins.
Results: During hemodialysis, albumin FSR and fibrinogen FSR increased significantly compared to the measurements obtained during baseline period. During this period, albumin and fibrinogen FSR increased 64% and 34%, respectively, compared to baseline (P < 0.05). While the increase in IL-6 concentration was modest during hemodialysis (14%), the levels further increased at the end of the 2-hour post-hemodialysis period (68% higher compared to baseline, P < 0.05). Fibrinogen FSR also demonstrated a further increase during the post-dialysis period (17% higher compared to the intradialytic period and 58% higher compared to baseline), while albumin FSR stabilized during this period.
Conclusions: The results provide clear evidence of hemodialysis-induced inflammatory response. The process is most notable during the 2-hour post-hemodialysis period.
Comment in
-
Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients.Kidney Int. 2003 Oct;64(4):1532-3. doi: 10.1046/j.1523-1755.2003.00246.x. Kidney Int. 2003. PMID: 12969179 No abstract available.
Similar articles
-
Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines.Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E658-64. doi: 10.1152/ajpendo.00444.2003. Epub 2004 Jan 13. Am J Physiol Endocrinol Metab. 2004. PMID: 14722024 Clinical Trial.
-
Exercise improves albumin fractional synthetic rate in chronic hemodialysis patients.Eur J Clin Nutr. 2007 May;61(5):686-9. doi: 10.1038/sj.ejcn.1602578. Epub 2006 Dec 20. Eur J Clin Nutr. 2007. PMID: 17180156 Clinical Trial.
-
Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.Mediators Inflamm. 2003 Feb;12(1):15-9. doi: 10.1080/0962935031000096935. Mediators Inflamm. 2003. PMID: 12745544 Free PMC article.
-
Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease.Kidney Int Suppl. 2003 May;(84):S94-7. doi: 10.1046/j.1523-1755.63.s84.20.x. Kidney Int Suppl. 2003. PMID: 12694319 Review.
-
Fibrinogen in hemodialysis: the worst of both worlds?Kidney Int. 2003 Jan;63(1):379-80. doi: 10.1046/j.1523-1755.2003.00748.x. Kidney Int. 2003. PMID: 12472807 Review. No abstract available.
Cited by
-
Procalcitonin serum levels in children undergoing chronic haemodialysis.Pediatr Nephrol. 2007 Mar;22(3):430-5. doi: 10.1007/s00467-006-0304-2. Epub 2006 Oct 17. Pediatr Nephrol. 2007. PMID: 17043886
-
Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.Kidney360. 2022 Jan 13;3(4):677-686. doi: 10.34067/KID.0006022021. eCollection 2022 Apr 28. Kidney360. 2022. PMID: 35721613 Free PMC article.
-
Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.Nutrients. 2018 Mar 23;10(4):397. doi: 10.3390/nu10040397. Nutrients. 2018. PMID: 29570616 Free PMC article.
-
Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.J Am Soc Nephrol. 2012 Feb;23(2):334-42. doi: 10.1681/ASN.2011030287. Epub 2011 Dec 8. J Am Soc Nephrol. 2012. PMID: 22158433 Free PMC article. Clinical Trial.
-
Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients.Int J Clin Exp Pathol. 2015 Oct 1;8(10):13477-82. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722560 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical